Corbus Pharmaceuticals Overview

Описание к видео Corbus Pharmaceuticals Overview

Yuval Cohen, PhD, CEO of Corbus Pharmaceuticals provides a compnay overview focusing on Lenabasum, a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in clinical studies for systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus

Комментарии

Информация по комментариям в разработке

Похожие видео